Terms: = Breast cancer AND SMAD3, JV15-2, 4088, ENSG00000166949, P84022, Smad3, MADH3, HsT17436, Smad 3, DKFZp686J10186, HSPC193, DKFZP586N0721, MGC60396 AND Prognosis
33 results:
1. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
2. Mutational signatures for breast cancer diagnosis using artificial intelligence.
Odhiambo P; Okello H; Wakaanya A; Wekesa C; Okoth P
J Egypt Natl Canc Inst; 2023 May; 35(1):14. PubMed ID: 37184779
[TBL] [Abstract] [Full Text] [Related]
3. Pleckstrin-2-promoted PPM1B degradation plays an important role in transforming growth factor-β-induced breast cancer cell invasion and metastasis.
Du L; Li J; Tian Y; Feng R
Cancer Sci; 2023 Jun; 114(6):2429-2444. PubMed ID: 36928924
[TBL] [Abstract] [Full Text] [Related]
4. Tumor suppressor DEAR1 regulates mammary epithelial cell fate and predicts early onset and metastasis in triple negative breast cancer.
Le UQ; Chen N; Balasenthil S; Lurie E; Yang F; Liu S; Rubin L; Solis Soto LM; Raso MG; Batra H; Sahin AA; Wistuba II; Killary AM
Sci Rep; 2022 Nov; 12(1):19504. PubMed ID: 36376460
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA SEMA3B-AS1 inhibits breast cancer progression by targeting miR-3940/KLLN axis.
Hu J; Huang H; Xi Z; Ma S; Ming J; Dong F; Guo H; Zhang H; Zhao E; Yao G; Yang L; Zhang F; Zheng W; Chen H; Huang T; Li L
Cell Death Dis; 2022 Sep; 13(9):800. PubMed ID: 36123344
[TBL] [Abstract] [Full Text] [Related]
6. RNA
Tan B; Zhou K; Liu W; Prince E; Qing Y; Li Y; Han L; Qin X; Su R; Pokharel SP; Yang L; Zhao Z; Shen C; Li W; Chen Z; Zhang Z; Deng X; Small A; Wang K; Leung K; Chen CW; Shen B; Chen J
Theranostics; 2022; 12(13):5727-5743. PubMed ID: 35966596
[TBL] [Abstract] [Full Text] [Related]
7. DGKZ promotes TGFβ signaling pathway and metastasis in triple-negative breast cancer by suppressing lipid raft-dependent endocytosis of TGFβR2.
Zhao Y; Sun H; Li X; Liu Q; Liu Y; Hou Y; Jin W
Cell Death Dis; 2022 Feb; 13(2):105. PubMed ID: 35115500
[TBL] [Abstract] [Full Text] [Related]
8. HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk.
Li H; Yang P; Wang J; Zhang J; Ma Q; Jiang Y; Wu Y; Han T; Xiang D
J Hematol Oncol; 2022 Jan; 15(1):2. PubMed ID: 34991659
[TBL] [Abstract] [Full Text] [Related]
9. MMP11 promotes the proliferation and progression of breast cancer through stabilizing smad2 protein.
Zhuang Y; Li X; Zhan P; Pi G; Wen G
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649832
[TBL] [Abstract] [Full Text] [Related]
10. Cisplatin prevents breast cancer metastasis through blocking early EMT and retards cancer growth together with paclitaxel.
Wang H; Guo S; Kim SJ; Shao F; Ho JWK; Wong KU; Miao Z; Hao D; Zhao M; Xu J; Zeng J; Wong KH; Di L; Wong AH; Xu X; Deng CX
Theranostics; 2021; 11(5):2442-2459. PubMed ID: 33500735
[TBL] [Abstract] [Full Text] [Related]
11. EEF1A2 interacts with HSP90AB1 to promote lung adenocarcinoma metastasis via enhancing TGF-β/smad signalling.
Jia L; Ge X; Du C; Chen L; Zhou Y; Xiong W; Xiang J; Li G; Xiao G; Fang L; Li Z
Br J Cancer; 2021 Mar; 124(7):1301-1311. PubMed ID: 33473168
[TBL] [Abstract] [Full Text] [Related]
12. Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells.
Ling Y; Cao Q; Liu Y; Zhao J; Zhao Y; Li K; Chen Z; Du X; Huo X; Kang H; Chen Z
Breast Cancer; 2021 Mar; 28(2):368-378. PubMed ID: 33047272
[TBL] [Abstract] [Full Text] [Related]
13. CD155 contributes to the mesenchymal phenotype of triple-negative breast cancer.
Zheng Q; Gao J; Yin P; Wang W; Wang B; Li Y; Zhao C
Cancer Sci; 2020 Feb; 111(2):383-394. PubMed ID: 31830330
[TBL] [Abstract] [Full Text] [Related]
14. EPB41L5 Mediates TGFβ-Induced Metastasis of Gastric cancer.
Jeong MH; Park SY; Lee SH; Seo J; Yoo JY; Park SH; Kim MJ; Lee S; Jang S; Choi HK; Lee JE; Shin SJ; Choi KC; Cheong JH; Yoon HG
Clin Cancer Res; 2019 Jun; 25(12):3617-3629. PubMed ID: 30814110
[TBL] [Abstract] [Full Text] [Related]
15. SMYD3 promotes the epithelial-mesenchymal transition in breast cancer.
Fenizia C; Bottino C; Corbetta S; Fittipaldi R; Floris P; Gaudenzi G; Carra S; Cotelli F; Vitale G; Caretti G
Nucleic Acids Res; 2019 Feb; 47(3):1278-1293. PubMed ID: 30544196
[TBL] [Abstract] [Full Text] [Related]
16. CD151 promotes breast cancer metastasis by activating TGF-β1/smad signaling pathway.
Zhao SJ; Zhao HD; Li J; Zhang H; Gao DT; Wang Q
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7314-7322. PubMed ID: 30468476
[TBL] [Abstract] [Full Text] [Related]
17. Sialylation of vasorin by ST3Gal1 facilitates TGF-β1-mediated tumor angiogenesis and progression.
Yeo HL; Fan TC; Lin RJ; Yu JC; Liao GS; Chen ES; Ho MY; Lin WD; Chen K; Chen CH; Hung JT; Wu JC; Chang NC; Chang MD; Yu J; Yu AL
Int J Cancer; 2019 Apr; 144(8):1996-2007. PubMed ID: 30252131
[TBL] [Abstract] [Full Text] [Related]
18. SOX4 can redirect TGF-β-mediated smad3-transcriptional output in a context-dependent manner to promote tumorigenesis.
Vervoort SJ; Lourenço AR; Tufegdzic Vidakovic A; Mocholi E; Sandoval JL; Rueda OM; Frederiks C; Pals C; Peeters JGC; Caldas C; Bruna A; Coffer PJ
Nucleic Acids Res; 2018 Oct; 46(18):9578-9590. PubMed ID: 30137431
[TBL] [Abstract] [Full Text] [Related]
19. Heterodimer formation by Oct4 and smad3 differentially regulates epithelial-to-mesenchymal transition-associated factors in breast cancer progression.
Mandal G; Biswas S; Roy Chowdhury S; Chatterjee A; Purohit S; Khamaru P; Chakraborty S; Mandal PK; Gupta A; de la Mare JA; Edkins AL; Bhattacharyya A
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2053-2066. PubMed ID: 29526821
[TBL] [Abstract] [Full Text] [Related]
20. Global Analysis of miRNA-mRNA Interaction Network in breast cancer with Brain Metastasis.
Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
[TBL] [Abstract] [Full Text] [Related]
[Next]